Nektar Therapeutics reported $25.22M in Cash and Equivalent for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Agios Pharmaceuticals AGIO:US $ 80.03M 123.1M
Amgen AMGN:US $ 6528M 1461M
Astrazeneca AZN:US $ 5762M 567M
Baxter International BAX:US $ 2294M 657M
Biocryst Pharmaceuticals BCRX:US $ 395.5M 108.88M
Biogen BIIB:US $ 1749.3M 512.1M
Bluebird Bio BLUE:US $ 106.26M 54.9M
Bristol Myers Squibb BMY:US $ 12369M 1610M
Cara Therapeutics CARA:US $ 21.36M 7.91M
Eisai 4523:JP Y 309633M 51213M
Eli Lilly And LLY:US $ 2459.2M 1359.3M
Esperion Therapeutics ESPR:US $ 150.36M 58.53M
Exelixis EXEL:US $ 723.27M 76.1M
Gilead Sciences GILD:US $ 4296M 1042M
GlaxoSmithKline GSK:LN 10967M 6693M
Halozyme Therapeutics HALO:US $ 117.84M 0.88M
Immunogen IMGN:US $ 437.66M 41.09M
Ironwood Pharmaceuticals IRWD:US $ 593.37M 26.76M
Karyopharm Therapeutics KPTI:US $ 153.26M 37.2M
Merk MRK:US $ 8556M 460M
Mirati Therapeutics MRTX:US $ 293.42M 100.32M
Nektar Therapeutics NKTR:US $ 25.22M 28.8M
Novartis NOVN:VX SF 13852M 1445M
Sarepta Therapeutics SRPT:US $ 1233.88M 881.99M
Seattle Genetics SGEN:US $ 261M 163.84M
Takeda 4502:JP Y 849695M 125354M
Teva Pharmaceutical TEVA:IT 2.18B 10M
Xencor XNCR:US $ 78.27M 65.21M
YTE INCY:US $ 2256.76M 199.32M